Panelist: Innovations in Psychedelics, Funding and the Future

Top universities are opening psychedelic research centers and investors are funding innovation in the private sector. The pace of change is rapid. What does the emerging landscape look like and what should we be most excited and cautious about regarding the evolution of psychedelic medicines and therapies? Hear perspectives from leaders in the space about the evolving science and business of psychedelics.

More About Shelby

Shelby Hartman is a co-founder and editor-in-chief of DoubleBlind, a media company and education platform at the forefront of the psychedelic movement. For years, Ms. Hartman has been reporting on psychedelics, cannabis, drug policy and mental health. Her work has appeared in Vice, Quartz, the Huffington Post and Rolling Stone, among others.